Drugs / YHB1411-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01525147 | Dec 2011 → Jun 2013 | rheumatoid arthritis | Yuhan Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YHB1411-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01525147 ↗ |
| Route | Intravenous | “IV infusion” NCT01525147 ↗ |